Mydecine Innovations Group Inc. (CSE: MYCO)
Canada
· Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
Dec 20, 2024, 3:56 PM EST
CSE: MYCO Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | - | - | - | 0.01 | 0 | 0.13 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | 186.32% | -97.92% | -39.53% | Upgrade
|
| Cost of Revenue | - | - | - | - | - | 0.09 | Upgrade
|
| Gross Profit | - | - | - | 0.01 | 0 | 0.03 | Upgrade
|
| Selling, General & Admin | 3.57 | 8.3 | 12.2 | 15.05 | 7.42 | 1.74 | Upgrade
|
| Research & Development | 3.41 | 1.08 | 3.51 | 3.96 | 1.29 | - | Upgrade
|
| Other Operating Expenses | - | - | - | - | 0.16 | 0.08 | Upgrade
|
| Operating Expenses | 6.99 | 9.39 | 15.84 | 22.34 | 11.42 | 3.47 | Upgrade
|
| Operating Income | -6.99 | -9.39 | -15.84 | -22.33 | -11.42 | -3.43 | Upgrade
|
| Interest Expense | -1.68 | -1.3 | -0.91 | -0.21 | -0.02 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0 | -0.18 | -0.36 | -0.11 | -0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.8 | -3.88 | 0.54 | -0.31 | 0.32 | 0.11 | Upgrade
|
| EBT Excluding Unusual Items | -12.48 | -14.58 | -16.39 | -23.2 | -11.23 | -3.39 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -4.75 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -5.14 | 0.96 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0.32 | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | - | -0.28 | 0.07 | Upgrade
|
| Other Unusual Items | 0.02 | -1.23 | - | -0.38 | -10.61 | -18.11 | Upgrade
|
| Pretax Income | -12.46 | -20.95 | -15.75 | -23.58 | -26.88 | -21.43 | Upgrade
|
| Earnings From Continuing Operations | -12.46 | -20.95 | -15.75 | -23.58 | -26.88 | -21.43 | Upgrade
|
| Earnings From Discontinued Operations | - | - | 6.5 | -5.31 | -0.07 | - | Upgrade
|
| Net Income | -12.46 | -20.95 | -9.25 | -28.9 | -26.95 | -21.43 | Upgrade
|
| Net Income to Common | -12.46 | -20.95 | -9.25 | -28.9 | -26.95 | -21.43 | Upgrade
|
| Shares Outstanding (Basic) | 57 | 31 | 9 | 5 | 2 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 57 | 31 | 9 | 5 | 2 | 0 | Upgrade
|
| Shares Change (YoY) | 163.36% | 254.98% | 84.71% | 105.85% | 410.54% | 307.17% | Upgrade
|
| EPS (Basic) | -0.22 | -0.68 | -1.07 | -6.17 | -11.85 | -48.11 | Upgrade
|
| EPS (Diluted) | -0.22 | -0.68 | -1.07 | -6.17 | -11.85 | -48.11 | Upgrade
|
| Free Cash Flow | -0.35 | -4.22 | -8.43 | -24.34 | -7.42 | -1.49 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.14 | -0.97 | -5.20 | -3.26 | -3.34 | Upgrade
|
| Gross Margin | - | - | - | 100.00% | 100.00% | 25.10% | Upgrade
|
| Operating Margin | - | - | - | -298069.65% | -436207.07% | -2734.55% | Upgrade
|
| Profit Margin | - | - | - | -385658.60% | -1029764.81% | -17065.34% | Upgrade
|
| Free Cash Flow Margin | - | - | - | -324889.79% | -283414.75% | -1183.48% | Upgrade
|
| EBITDA | -6.98 | -9.38 | -15.71 | -22.19 | -11.24 | -3.43 | Upgrade
|
| D&A For EBITDA | 0.01 | 0.01 | 0.13 | 0.15 | 0.17 | 0 | Upgrade
|
| EBIT | -6.99 | -9.39 | -15.84 | -22.33 | -11.42 | -3.43 | Upgrade
|
| Advertising Expenses | - | - | - | - | - | 0.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.